| CERVOMED INC. DL-,001 |
| USA |
| Gesundheit |
| US15713L1098 / A3ES01 |
| DP8 (Frankfurt) / CRVO (NASDAQ) |
| FRA:DP8, ETR:DP8, DP8:GR, NASDAQ:CRVO |
| - |
| https://www.cervomed.com/ |
|
CervoMed Inc. is a biotechnology company focused on developing treatments for neurodegenerative diseases. With a commitment to improving patient outcomes, the company engages in the research and development of innovative therapies that target underly..
>Volltext.. |
| 19.61 Mio. EUR |
| 8.42 Mio. EUR |
| 1.81 Mio. EUR |
| -26.89 Mio. EUR |
| -25.97 Mio. EUR |
| -2.83 EUR |
| - |
| 6.87 Mio. EUR |
| -23.84 Mio. EUR |
| 2.87 |
| -78.99% |
| -50.64% |
| - |
| - |
| - |
| - |
| CERVOMED |
| 15.06.26 |
|